Table 3.
Disease pathway pattern groups of the included SSBs models
| Pathway pattern | N (%) | Studies ID | References | |
|---|---|---|---|---|
| Group 1 | Only BMI | 7 (17.5%) | Briggs 2013a, Briggs 2013b, Kristensen 2014, Lee 2018, Manyema 2014, Vecino-Ortiz 2018, Wilson 2015. | [25, 46, 47, 55, 57, 62, 72] |
| Group 2 | BMI + BMI-related conditions / consequences | 13 (32.5%) | Collins 2015, Gortmaker 2015b, Gortmaker 2015a, Lin 2011, Long 2015, Manyema 2015, Manyema 2016, Nomaguchi 2017, Pearson-Stuttard 2017, Rezende 2016, Sacks 2011, Singh 2015, Wright 2015 | [23, 26, 27, 32, 51, 53, 54, 59, 61, 64, 65, 67, 73] |
| Group 3 | BMI + BMI-related conditions + Diabetes | 14 (35.0%) | Afshin 2015, Basu 2013, Brown 2018, Breeze 2017, Briggs 2017, Cobiac 2017, Crino 2017, Lal 2017, Magnus 2016, Mekonnen 2013, Penalvo 2017, Sanchez Romero 2016, Veerman 2016, Wang 2012 | [18, 40, 43, 45, 48–50, 52, 56, 61, 66, 68, 70, 71] |
| Group 4 | BMI + Diabetes | 4 (10.0%) | Barrientos-G. 2017, Basu 2014 a, Basu 2014b, Ma 2016 | [41, 42, 44, 60] |
| Group 5 | Other, such as cavities, → costs | 1 (2.5%) | Schwendicke 2016 | [69] |
| Group 6 | Other → any other | 1 (2.5%) | Lieffers 2018 | [58] |